INTEGRA Biosciences AG manufactures laboratory instruments and consumables at two production sites in Switzerland and the United States.

Based on our current assessment, we do not anticipate any impact on supply continuity related to the conflict in the Middle East. At this time, we are not experiencing delays, material shortages, or manufacturing disruptions.

To support reliable supply, INTEGRA maintains mitigation measures including dual manufacturing sites, safety stock, and diversified logistics routes. We continue to monitor the situation closely.

If you have any questions, please contact your usual INTEGRA representative.